- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
XCell Therapeutics Inc (373110)
Track today's live XCell Therapeutics (373110) share price, performance and key data on this page with our current KOSDAQ:373110 stock exchange information. Analyse interactive charts and historical data, check technical buy and sell signals in real time, and follow the XCell Therapeutics share price on the KOSDAQ exchange. Use the dropdown to switch exchange for the 373110 share price, head to our technical summary section, which provides analysis on XCell Therapeutics share price buy/sell indicators using real-time data (or discuss the XCell Therapeutics (373110) stock price today with other investors in the XCell Therapeutics KQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current KQ:373110 share price (ISIN: KR7373110006) to enhance your trading decisions with our free investment tools and resources.
What Is the XCell Therapeutics Inc Share Price Today?
The XCell Therapeutics share price today is 1,379.
What Is the Stock Symbol for XCell Therapeutics Inc
The stock symbol (or 'ticker') for XCell Therapeutics Inc is "373110."
What Stock Exchange Does XCell Therapeutics Inc Trade On?
XCell Therapeutics Inc is listed and trades on the KOSDAQ stock exchange.
Is XCell Therapeutics Inc a Good Stock to Buy?
Determining whether XCell Therapeutics (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
Use the dropdown to select a relevant stock exchange for the current KQ:373110 share price (ISIN: KR7373110006) to enhance your trading decisions with our free investment tools and resources.
What Is the XCell Therapeutics Inc Share Price Today?
The XCell Therapeutics share price today is 1,379.
What Is the Stock Symbol for XCell Therapeutics Inc
The stock symbol (or 'ticker') for XCell Therapeutics Inc is "373110."
What Stock Exchange Does XCell Therapeutics Inc Trade On?
XCell Therapeutics Inc is listed and trades on the KOSDAQ stock exchange.
Is XCell Therapeutics Inc a Good Stock to Buy?
Determining whether XCell Therapeutics (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
KOSDAQ
Currency in KRW
1,379
+65(+4.95%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1,262
1,383
52 wk Range
1,009
4,035
373110 is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1,2621,383
52 wk Range
1,0094,035
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
373110 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Significant return over the last week
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Earnings
Latest Release
15/05/2026
EPS / Forecast
-169.38 / --
Revenue / Forecast
1.02B / --
Compare 373110 to Peers and Sector
Metrics to compare | 373110 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship373110PeersSector | |
|---|---|---|---|---|
P/E Ratio | −2.1x | −5.5x | −0.4x | |
PEG Ratio | −0.23 | −0.09 | 0.00 | |
Price/Book | 3.6x | 1.8x | 2.6x | |
Price / LTM Sales | 8.9x | 5.1x | 3.1x | |
Upside (Analyst Target) | - | 0.0% | 48.5% | |
Fair Value Upside | Unlock | 6.9% | 5.8% | Unlock |
Xcell Therapeutics Inc. engages in the development and production of drugs for cell therapy. It offers CellCor, a serum-free chemically defined medium that is used to develop human mesenchymal stem cells. The company also offers XPorT, a platform that aims to develop optimal media from the perspective of the user using a variety of cells. In addition, it develops media for cell culture in various areas of the bioindustry such as cell therapy, gene therapy, exosomes, organoids and bioreactors. Xcell Therapeutics Inc. was founded in 2015 and is based in Seoul, South Korea.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the XCell Therapeutics (KOSDAQ: 373110) Share Price Today?
The XCell Therapeutics stock price today is 1,379 KRW.
What Stock Exchange Does XCell Therapeutics (373110) Trade On?
XCell Therapeutics is listed and trades on the KOSDAQ.
What Is the Ticker (Stock Symbol) for XCell Therapeutics?
The stock symbol (also called a 'ticker') for XCell Therapeutics is "373110."
What Is the Current XCell Therapeutics Market Capitalisation?
As of today, XCell Therapeutics (KOSDAQ: 373110) market cap is 23.85B KRW.
What Is XCell Therapeutics's (373110) Earnings Per Share (TTM)?
The XCell Therapeutics EPS is currently -854 (Trailing Twelve Months).
Is 373110 a Buy or Sell From a Technical Analyst Perspective?
Based on today's XCell Therapeutics moving averages and other technical indicators, the daily buy/sell signal for 373110 stock is Strong Buy.
How Many Times Has XCell Therapeutics Stock Split?
XCell Therapeutics has split 0 times. (See the 373110 stock split history page for full effective split date and price information.)
What is the current trading status of XCell Therapeutics (KOSDAQ: 373110)?
As of 10/08/2026, XCell Therapeutics (373110) is trading at a share price of 1,379 KRW, with a previous close of 1,314 KRW. The stock has fluctuated within a day range of 1,262 KRW to 1,383 KRW, while its 52-week range spans from 1,009 KRW to 4,035 KRW.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.